How much funding has Hyperion Therapeutics raised?

Hyperion Therapeutics has raised $117.5M in total funding, most recently a Venture Round.

When was Hyperion Therapeutics founded?

Hyperion Therapeutics was founded in 2006.

Where is Hyperion Therapeutics headquartered?

Hyperion Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Hyperion Therapeutics in?

Hyperion Therapeutics operates in biotechnology, specialty therapeutics.

How many employees does Hyperion Therapeutics have?

Hyperion Therapeutics has 51-200 employees.

Hyperion Therapeutics

Closed

South San Francisco, United States · Founded 2006 · $117.5M raised

biotechnology

specialty therapeutics

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2006
Business Model: B2B

Total Funding: $117.5M
Last Round: $17.5M Venture RoundApr 2011
Rounds: 4

About

Hyperion Therapeutics was a Brisbane, CA-based commercial-stage biopharmaceutical company founded in 2006, focused on orphan diseases. The company developed and commercialized RAVICTI (glycerol phenylbutyrate) and BUPHENYL for urea cycle disorders. Hyperion went public on Nasdaq before being acquired by Horizon Pharma in May 2015 for approximately $1.1 billion.

Summary

Hyperion Therapeutics is a biotechnology company based in South San Francisco, United States, founded in 2006. It has raised $117.5M in total across 4 rounds, most recently a $17.5M Venture Round round in Apr 2011.